The global nuclear medicine market is projected to reach $12.34 billion in 2027, growing at a compound annual growth rate (CAGR) of 12.5%. The market includes diagnostic and therapeutic services for cardiovascular diseases (CVDs) and cancer. North America was the largest region in the nuclear medicine market in 2022, with Asia-Pacific expected to be the fastest-growing region. Key players in the market are focusing on product innovation to strengthen their position. ResearchAndMarkets.com is a leading source for international market research reports and data.
Wed, 16 Aug 2023 08:54:30 GMT | GlobeNewswire